Smaldone Alsup Laurie

Director at HUMANIGEN, INC · on record since Oct 23, 2013
Director at Theravance Biopharma, Inc. · on record since Jun 16, 2026
Director at ARVINAS, INC. · on record since Nov 22, 2019
Director at BLACKBERRY Ltd · on record since Mar 2, 2020
Director at Kinnate Biopharma Inc. · on record since Dec 2, 2020
Director at PARDES BIOSCIENCES, INC. · on record since Sep 16, 2022

Insider trading activity of Smaldone Alsup Laurie

Transactions on record: 77; since Oct 23, 2013

Open-market buys: 0

Open-market sells: 0

Companies traded: 6; last filing Sep 24, 2026

Figures computed from official regulatory filings — .

Companies where Smaldone Alsup Laurie has traded

Theravance Biopharma, Inc.33 tx · Sep 24, 2026
ARVINAS, INC.12 tx · Jun 26, 2026
BLACKBERRY Ltd18 tx · Jun 26, 2024
Kinnate Biopharma Inc.7 tx · Apr 5, 2024
PARDES BIOSCIENCES, INC.4 tx · Aug 31, 2023
HUMANIGEN, INC3 tx · Jul 14, 2015

Track record of Smaldone Alsup Laurie

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Smaldone Alsup Laurie

Co-insiders of Smaldone Alsup Laurie

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-24,258	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-13,398	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-28,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-22,044	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	Other	-74,980	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	Other	-6,009	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-23,576	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-13,500	—	n/a (No price was disclosed in the filing)	SEC
ARVINAS, INC.Listing on record	Jun 26, 2026	Award	15,527	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	Jun 26, 2026	AwardD (derivative)	22,714	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	Jun 16, 2026	Award	6,009	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	Jun 16, 2026	AwardD (derivative)	13,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	Jun 27, 2025	AwardD (derivative)	23,105	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	Jun 27, 2025	Award	16,025	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	AwardD (derivative)	24,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	Award	10,649	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BLACKBERRY LtdListing on record	Jun 26, 2024	AwardD (derivative)	5,994	—	n/a (No price was disclosed in the filing)	SEC
BLACKBERRY LtdListing on record	Jun 4, 2024	AwardD (derivative)	17,763	—	n/a (No price was disclosed in the filing)	SEC
ARVINAS, INC.Listing on record	May 31, 2024	AwardD (derivative)	9,070	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	May 31, 2024	Award	5,899	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	May 10, 2024	AwardD (derivative)	23,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-24,258	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-13,398	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-28,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-22,044	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	Other	-74,980	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	Other	-6,009	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-23,576	—	n/a (No price was disclosed in the filing)	SEC
Theravance Biopharma, Inc.Listing on record	Sep 24, 2026	OtherD (derivative)	-13,500	—	n/a (No price was disclosed in the filing)	SEC
ARVINAS, INC.Listing on record	Jun 26, 2026	Award	15,527	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	Jun 26, 2026	AwardD (derivative)	22,714	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	Jun 16, 2026	Award	6,009	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	Jun 16, 2026	AwardD (derivative)	13,398	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	Jun 27, 2025	AwardD (derivative)	23,105	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	Jun 27, 2025	Award	16,025	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	AwardD (derivative)	24,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	Award	10,649	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BLACKBERRY LtdListing on record	Jun 26, 2024	AwardD (derivative)	5,994	—	n/a (No price was disclosed in the filing)	SEC
BLACKBERRY LtdListing on record	Jun 4, 2024	AwardD (derivative)	17,763	—	n/a (No price was disclosed in the filing)	SEC
ARVINAS, INC.Listing on record	May 31, 2024	AwardD (derivative)	9,070	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARVINAS, INC.Listing on record	May 31, 2024	Award	5,899	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Theravance Biopharma, Inc.Listing on record	May 10, 2024	AwardD (derivative)	23,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC